THE EVALUATION OF IMMUNE RESPONSES TO SARS-COV-2 MRNA VACCINES IN MULTIPLE SCLEROSIS PATIENTS ON OCRELIZUMAB

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Observational

Locations

Outpatient CTRC
University of Colorado Hospital

Study ID

Protocol Number: 21-3126

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers